-
1
Teplizumab - current state of knowledge on the effects of teplizumab in preventing the development of type 1 diabetes in people at risk
Published 2023-08-01Subjects: “…teplizumab…”
Get full text
Article -
2
Lessons and gaps in the prediction and prevention of type 1 diabetes
Published 2023-07-01Subjects: Get full text
Article -
3
El desafío de prevenir y tratar una enfermedad con gran heterogeneidad
Published 2023-12-01Subjects: Get full text
Article -
4
Approaches to Measuring Beta Cell Reserve and Defining Partial Clinical Remission in Paediatric Type 1 Diabetes
Published 2024-02-01Subjects: Get full text
Article -
5
From pre-clinical efficacy to promising clinical trials that delay Type 1 diabetes
Published 2024-10-01Subjects: Get full text
Article -
6
Teplizumab: toma de posición de la Sociedad Argentina de Diabetes
Published 2023-12-01Subjects: “…teplizumab…”
Get full text
Article -
7
Sex-oriented perspectives in immunopharmacology
Published 2023-11-01Subjects: Get full text
Article -
8
Teplizumab’s immunomodulatory effects on pancreatic β-cell function in type 1 diabetes mellitus
Published 2024-08-01Subjects: “…Teplizumab…”
Get full text
Article -
9
Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies
Published 2025-01-01Subjects: Get full text
Article -
10
Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies
Published 2024-11-01Subjects: Get full text
Article